Literature DB >> 9872195

Factors related to the relapse of bronchiolitis obliterans organizing pneumonia.

K Watanabe1, S Senju, F Q Wen, T Shirakusa, F Maeda, M Yoshida.   

Abstract

STUDY
OBJECTIVE: The purpose of this study is to determine factors, including laboratory data, related to the relapse of bronchiolitis obliterans organizing pneumonia (BOOP).
DESIGN: Retrospective study. SETTING AND PATIENTS: The medical files of Fukuoka University Hospital and Nishi Fukuoka Hospital patients from 1984 to 1996 were reviewed, and 18 cases of BOOP that had been diagnosed using transbronchial or open lung biopsy were selected for evaluation. MEASUREMENTS: The 18 cases were put into two groups composed of 7 patients who relapsed and 11 who did not relapse. Their clinical symptoms and laboratory data at first admission, including hemograms, blood chemistry tests, and pulmonary function tests were compared. Patients with or without associated diseases, such as collagen vascular diseases, were compared using the same parameters in order to examine the relationship between the associated diseases and BOOP relapse.
RESULTS: The serum levels of total protein and albumin in patients who relapsed were significantly lower than in patients who did not relapse, respectively: 5.8 (range, 4.4 to 6.2) vs 6.3 (range, 4.5 to 6.8) g/dL, p < 0.05; and 2.9 (range, 2.5 to 3.4) vs 3.7 (range, 2.8 to 4.3) g/dL, p < 0.01. Levels of serum albumin in BOOP patients with associated diseases, however, were significantly lower than in those without associated diseases, respectively: 2.95 (range, 2.5 to 3.9) vs 3.65 (range, 2.8 to 4.3) mg/dL, p < 0.05. The fall in serum albumin levels in patients who relapsed, therefore, was probably due to associated diseases. The fact that 5 of 8 patients with associated diseases relapsed but only 2 of 10 without associated diseases relapsed suggests that a relationship exists between associated diseases and the prognosis of BOOP, although this finding was not statistically significant because of the small number of cases and the heterogeneity of the associated diseases. The most striking observation was that PaO2 levels in patients who relapsed were significantly lower than in those who did not, respectively: 55.4 (range, 39.9 to 73.2) vs 78.0 (range, 48.4 to 89.4) mm Hg, p < 0.05. However, PaO2 levels were not statistically different between patients with and without associated diseases, respectively: 66.0 (range, 45.4 to 78.8) vs 71.4 (range, 39.9 to 89.4) mm Hg.
CONCLUSIONS: The severity of hypoxemia at first medical examination may be an important determinant for the subsequent BOOP relapse.

Entities:  

Mesh:

Year:  1998        PMID: 9872195     DOI: 10.1378/chest.114.6.1599

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Systematic review of postradiotherapy bronchiolitis obliterans organizing pneumonia in women with breast cancer.

Authors:  Gary R Epler; Eileen M Kelly
Journal:  Oncologist       Date:  2014-10-31

3.  Predictors of Relapse in Patients with Organizing Pneumonia.

Authors:  Minjung Kim; Seung-Ick Cha; Hyewon Seo; Kyung-Min Shin; Jae-Kwang Lim; Hyera Kim; Seung-Soo Yoo; Jaehee Lee; Shin-Yup Lee; Chang-Ho Kim; Jae-Yong Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

4.  Organizing pneumonia revisited: insights and uncertainties from a series of 67 patients.

Authors:  A L Vieira; A Vale; N Melo; P Caetano Mota; J M Jesus; R Cunha; S Guimarães; C Souto Moura; A Morais
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

5.  Clinical significance of intra-alveolar fibrin deposition in transbronchial lung biopsy in patients with organizing pneumonia.

Authors:  Nobuhiko Nagata; Kentaro Wakamatsu; Hiroyuki Kumazoe; Hiroyuki Miyazaki; Takanori Akagi; Masayuki Kawasaki; Kentaro Watanabe
Journal:  Lung       Date:  2015-02-06       Impact factor: 2.584

6.  Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study.

Authors:  Elżbieta Radzikowska; Elżbieta Wiatr; Renata Langfort; Iwona Bestry; Agnieszka Skoczylas; Ewa Szczepulska-Wójcik; Dariusz Gawryluk; Piotr Rudziński; Joanna Chorostowska-Wynimko; Kazimierz Roszkowski-Śliż
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

7.  A long-term retrospective study of patients with biopsy-proven cryptogenic organizing pneumonia.

Authors:  Ying Zhou; Lei Wang; Mei Huang; Jingjing Ding; Hanyi Jiang; Kefeng Zhou; Fanqing Meng; Yonglong Xiao; Hourong Cai; Jinghong Dai
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.